Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2009
08/12/2009EP2087910A2 Polymeric prodrugs
08/12/2009EP2087909A1 Formulation of an injectable paracetamol solution, method of manufacturing and packaging such a solution and device for packaging such a solution
08/12/2009EP2087903A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof
08/12/2009EP2087890A1 Sustained release preparation for tissue regeneration therapy
08/12/2009EP2087887A1 Highly absorbable composition for oral administration containing oxidized coenzyme q10
08/12/2009EP2087883A1 Stabilised supersaturated solid solutions of steroidal drugs
08/12/2009EP2087882A1 Drug microparticles
08/12/2009EP2087103A1 Cancerous disease modifying antibodies
08/12/2009EP2086954A1 Composition comprising (-)-delta 9-trans-tetrahydrocannabinol
08/12/2009EP2086603A2 Method for preparing an implantable prosthesis from a porous base body and associated prosthesis and use thereof
08/12/2009EP2086588A2 N-terminal pegylated prolactin receptor molecules
08/12/2009EP2086587A2 Use of a fusion protein between a cytokine and an antibody targeting the ed-b fibronectin domain for the treatment of atherosclerosis
08/12/2009EP2086586A2 Anti-microorganism terpenic composition
08/12/2009EP2086575A2 Light-mediated anti-cell proliferative compositions and methods
08/12/2009EP2086567A1 Sustained release formulations comprising very low molecular weight polymers
08/12/2009EP2086529A2 Antimicrobial compositions and related applications
08/12/2009EP2086524A1 Transnasal anticonvulsive pharmaceutical composition
08/12/2009EP2086521A2 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs
08/12/2009EP2086505A2 Injectable depot composition and its process of preparation
08/12/2009EP2086504A2 Diclofenac gel
08/12/2009EP2086344A1 Process for obtaining leguminous protein fractions of moderate molecular weight, leguminous protein fractions and use thereof
08/12/2009EP2086316A2 Subunguicide, and method for treating onychomycosis
08/12/2009EP1755662B1 Combined meningococcal conjugates with common carrier protein
08/12/2009EP1720518B1 Alginate viscoelastic composition, method of use and package
08/12/2009EP1635854A4 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
08/12/2009EP1525478B1 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3-expressing tumors
08/12/2009EP1501774B1 Polyunsaturated linear aldehydes and their derivatives with anti-radical activity
08/12/2009EP1409645B1 Probiotic lactobacillus salivarius strains
08/12/2009EP1401376A4 Colloidal metal compositions and methods
08/12/2009EP1379257B1 Prodrugs of anticancer agents employing substituted aromatic acids
08/12/2009EP1294402B2 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds
08/12/2009EP1274319B1 Compositions and methods for improving vascular health
08/12/2009EP1255780B1 Methods for generating human monoclonal antibodies
08/12/2009EP1198589B9 Tenascin-c nucleic acid ligands
08/12/2009EP0674505B2 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails
08/12/2009CN101505800A Preparation of pegylated conjugates of VLA-4 antagonists via a Mitsunobu's reaction
08/12/2009CN101505799A Pharmaceutical composition for administration by injection
08/12/2009CN101505798A Aerosol formulation for the inhalation of beta agonists
08/12/2009CN101505726A Pharmaceutical suspensions comprising phenylephrine and method of preparation
08/12/2009CN101505722A Flowable carrier matrix
08/12/2009CN101505712A Compositions based on hyperbranched condensation polymers and novel hyperbranched condensation polymers
08/12/2009CN101503564A Composite biodegradation material and use
08/12/2009CN101503480A Microwave synthesizing method for disproportionated rosin-chitosan conjugate
08/12/2009CN101503473A Targeted polypeptide for diagnosing and treating lung cancer in vivo and in vitro and use thereof
08/12/2009CN101503370A Method for synthesizing N-cyclopropyl-trans-2-cis-6-nonadienoic acid acidamide
08/12/2009CN101502660A Medicine-carrying polylactic acid microcapsular ultrasound contrast agent and preparation method thereof
08/12/2009CN101502657A Method for constructing phage vector vaccine fused with gp350 protein of EB virus
08/12/2009CN101502656A Composition for eliminating bitter taste of soluble and stable macrolides medicament
08/12/2009CN101502655A Method for preparing pH-sensitive photocrosslinkable hydrogel
08/12/2009CN101502654A Preparation method of high-gloss high-stability Elsinochrome silicon oxide nano granule and application thereof in preparing intravenous injection agent
08/12/2009CN101502649A Liposome influenza vaccine
08/12/2009CN101502644A Applications of hCRF and derivatives thereof in preparing medicament for treating alveolar hypoventilation syndrome
08/12/2009CN101502643A Applications of hCRF and derivatives thereof in preparing medicament for treating Guillain Barre syndrome
08/12/2009CN101502641A Ciclosporin medicament composition for injection administration
08/12/2009CN101502608A Chinese paris rhizome total sapogenin oral medication preparation as well as preparation method and application thereof
08/12/2009CN101502568A Oral liquid for beauty treatment and face nursing and preparation method thereof
08/12/2009CN101502562A Medicament composition for protecting and promoting regeneration function of hepatocyte and preparation method
08/12/2009CN101502558A Method for preparing astragalus total saponin injection from cyclodextrin composition
08/12/2009CN101502553A Rhizoma atractylodis total terpene alcohol solid dispersoid, medicament composition and preparation method thereof
08/12/2009CN101502539A Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation
08/12/2009CN101502500A Pressurised metered dose inhalers containing solutions of beta-2 agonists
08/12/2009CN101502499A Ibuprofen percutaneous release patch and preparation method thereof
08/12/2009CN101502498A Curcumin preparation for percutaneous administration and preparation method thereof
08/12/2009CN101502497A Fenofibrate medicament composition
08/12/2009CN101502496A Method for preparing norfloxacin capsule
08/12/2009CN101502495A Pemirolast Potassium and technique for producing the same
08/12/2009CN101502494A Bromhexine hydrochloride freeze-dried injection and preparation method thereof
08/12/2009CN101502492A Method for preparing clarithromycin granule without bitter taste
08/12/2009CN101502491A Dirithromycin enteric-coated formulation
08/12/2009CN101502490A Ketoprofen bioadhesive gel microsphere and preparation method thereof
08/12/2009CN101502488A Teniposide emulsion and preparation method thereof
08/12/2009CN101502486A Antineoplastic 2-methoxyestradiol injection containing cyclodextrin or cyclodextrin derivates
08/12/2009CN101502485A Nano cubic liquid crystal dexamethasone preparation for eye and preparation method thereof
08/12/2009CN101502484A Glucocorticosteroid and chemotherapy medicament carried by anticancer sustained-release agent
08/12/2009CN100526463C Methods for making Apo-2 ligand using divalent metal ions
08/12/2009CN100526309C Dimeric compounds and their use as anti-viral agents
08/12/2009CN100526289C Non-toxic ion liquid its production and use
08/12/2009CN100525837C Application of cytoplasm targeting administration system capable of reversing tumor cell resistance
08/12/2009CN100525836C Double-head radical lipid prodrug
08/12/2009CN100525835C Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent
08/12/2009CN100525833C A method for forming dextran 40/polypeptide freeze dried powder injection solution
08/12/2009CN100525831C Improved pharmaceutical botulinum toxin compositions
08/12/2009CN100525830C Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod
08/12/2009CN100525774C DiAo Xinxuekang soft capsule and preparation process and use thereof
08/12/2009CN100525769C Sustained release formulation of raltitrexed and preparation method thereof
08/12/2009CN100525767C Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
08/12/2009CN100525756C Coated ubenimex table
08/12/2009CN100525752C Production of release-controlled film in percutaneous medicine-feeding system
08/11/2009US7572893 Suitable for lyophilization, protein capable of binding and inhibiting the biological action of IL-1,histidine, glycine, arginine, sucrose, stability; resistant to degradation, aggregation, oxidation, and other degenerative processes while in the freeze dried state
08/11/2009US7572887 Gene expressed in prostate cancer, methods and use thereof
08/11/2009US7572833 E.g., N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal stabilized with a lipid; improved absorption and penetration; treating ischemia, immune diseases, Alzheimer's disease, osteoporosis, brain disorders, eye diseases, osteoporosis
08/11/2009US7572804 Macrolides
08/11/2009US7572782 Use of targeted oxidative therapeutic formulation in bone regeneration
08/11/2009US7572779 Improved oral bioavailability of 17 beta-estradiol by adminstering the lower alkanoate; contraceptives, hormone replacement therapy
08/11/2009US7572773 Single dose fast dissolving azithromycin
08/11/2009US7572764 Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds
08/11/2009US7572605 1,2,3,tris(4-hydroxy-butyroyloxy)propane; enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, and target specific organs
08/11/2009US7572598 Preparation comprising albumin esterified with a labeled substance for diagnosis of pancreatic exocrine function
08/11/2009US7572474 Administering polydextrose, glycosides; for increasing production of acetate, decreasing production of butyrate, increasing population and species of beneficial bacteria and slowing rate of fermentation of prebiotics within gut
08/11/2009US7572463 Oral dosage forms
1 ... 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 ... 1712